FY25 consensus $1.15. Backs FY25 revenue view of $5.3B-$5.5B, consensus $5.4B. Backs FY25 adjusted EBITDA in the range of $510M-$530M.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SEM:
- Select Medical reports Q3 adjusted EPS 23c, consensus 15c
- Is SEM a Buy, Before Earnings?
- Select Medical price target raised to $20 from $16 at RBC Capital
- Positive Outlook for Select Medical Amid CMS Rule Delay and Strength in Inpatient Rehabilitation
- Select Medical price target lowered to $15 from $18 at BofA